ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Live Herpes Zoster Vaccine Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-36P17034
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Live Herpes Zoster Vaccine Market Research Report 2024
BUY CHAPTERS

Global Live Herpes Zoster Vaccine Market Research Report 2024

Code: QYRE-Auto-36P17034
Report
May 2024
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Companies
Merck
GSK
SK
Changchun BCHT Biotechnology
SIBP CNBG

Live Herpes Zoster Vaccine Market

Live Herpes Zoster Vaccine refers to a vaccine used to prevent shingles. Shingles is a disease caused by the varicella-zoster virus, which usually reoccurs years after a chickenpox infection. This vaccine is attenuated, using a live virus strain that has been weakened, hence the name attenuated vaccine. Vaccination with the attenuated shingles vaccine can help prevent or reduce episodes of shingles and reduce the risk of complications. (Now all companies have achieved commercial production, except for SIBP CNBG, which is in the Phase II experimental stage.)
The global Live Herpes Zoster Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Live Herpes Zoster Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Live Herpes Zoster Vaccine include Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Live Herpes Zoster Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Herpes Zoster Vaccine.
The Live Herpes Zoster Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Live Herpes Zoster Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Herpes Zoster Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Live Herpes Zoster Vaccine Market Report

Report Metric Details
Report Name Live Herpes Zoster Vaccine Market
Segment by Type
  • Single-dose Vaccination
  • Double-dose Vaccination
Segment by Application
  • Public Health Sector
  • Hospitals & clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Live Herpes Zoster Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Live Herpes Zoster Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Live Herpes Zoster Vaccine Market report?

Ans: The main players in the Live Herpes Zoster Vaccine Market are Merck, GSK, SK, Changchun BCHT Biotechnology, SIBP CNBG

What are the Application segmentation covered in the Live Herpes Zoster Vaccine Market report?

Ans: The Applications covered in the Live Herpes Zoster Vaccine Market report are Public Health Sector, Hospitals & clinics, Others

What are the Type segmentation covered in the Live Herpes Zoster Vaccine Market report?

Ans: The Types covered in the Live Herpes Zoster Vaccine Market report are Single-dose Vaccination, Double-dose Vaccination

1 Live Herpes Zoster Vaccine Market Overview
1.1 Product Definition
1.2 Live Herpes Zoster Vaccine by Type
1.2.1 Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Single-dose Vaccination
1.2.3 Double-dose Vaccination
1.3 Live Herpes Zoster Vaccine by Application
1.3.1 Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030)
1.3.2 Public Health Sector
1.3.3 Hospitals & clinics
1.3.4 Others
1.4 Global Live Herpes Zoster Vaccine Market Size Estimates and Forecasts
1.4.1 Global Live Herpes Zoster Vaccine Revenue 2019-2030
1.4.2 Global Live Herpes Zoster Vaccine Sales 2019-2030
1.4.3 Global Live Herpes Zoster Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Live Herpes Zoster Vaccine Market Competition by Manufacturers
2.1 Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Live Herpes Zoster Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Live Herpes Zoster Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Enter into This Industry
2.8 Global Live Herpes Zoster Vaccine Market Competitive Situation and Trends
2.8.1 Global Live Herpes Zoster Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Herpes Zoster Vaccine Players Market Share by Revenue
2.8.3 Global Live Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Herpes Zoster Vaccine Market Scenario by Region
3.1 Global Live Herpes Zoster Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Live Herpes Zoster Vaccine Sales by Region: 2019-2030
3.2.1 Global Live Herpes Zoster Vaccine Sales by Region: 2019-2024
3.2.2 Global Live Herpes Zoster Vaccine Sales by Region: 2025-2030
3.3 Global Live Herpes Zoster Vaccine Revenue by Region: 2019-2030
3.3.1 Global Live Herpes Zoster Vaccine Revenue by Region: 2019-2024
3.3.2 Global Live Herpes Zoster Vaccine Revenue by Region: 2025-2030
3.4 North America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.4.1 North America Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.4.3 North America Live Herpes Zoster Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.5.1 Europe Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.5.3 Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Herpes Zoster Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Live Herpes Zoster Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.7.1 Latin America Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Live Herpes Zoster Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Live Herpes Zoster Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Herpes Zoster Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Herpes Zoster Vaccine Sales by Type (2019-2030)
4.1.1 Global Live Herpes Zoster Vaccine Sales by Type (2019-2024)
4.1.2 Global Live Herpes Zoster Vaccine Sales by Type (2025-2030)
4.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Live Herpes Zoster Vaccine Revenue by Type (2019-2030)
4.2.1 Global Live Herpes Zoster Vaccine Revenue by Type (2019-2024)
4.2.2 Global Live Herpes Zoster Vaccine Revenue by Type (2025-2030)
4.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Live Herpes Zoster Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Live Herpes Zoster Vaccine Sales by Application (2019-2030)
5.1.1 Global Live Herpes Zoster Vaccine Sales by Application (2019-2024)
5.1.2 Global Live Herpes Zoster Vaccine Sales by Application (2025-2030)
5.1.3 Global Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Live Herpes Zoster Vaccine Revenue by Application (2019-2030)
5.2.1 Global Live Herpes Zoster Vaccine Revenue by Application (2019-2024)
5.2.2 Global Live Herpes Zoster Vaccine Revenue by Application (2025-2030)
5.2.3 Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Live Herpes Zoster Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Live Herpes Zoster Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Live Herpes Zoster Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 SK
6.3.1 SK Company Information
6.3.2 SK Description and Business Overview
6.3.3 SK Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SK Live Herpes Zoster Vaccine Product Portfolio
6.3.5 SK Recent Developments/Updates
6.4 Changchun BCHT Biotechnology
6.4.1 Changchun BCHT Biotechnology Company Information
6.4.2 Changchun BCHT Biotechnology Description and Business Overview
6.4.3 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product Portfolio
6.4.5 Changchun BCHT Biotechnology Recent Developments/Updates
6.5 SIBP CNBG
6.5.1 SIBP CNBG Company Information
6.5.2 SIBP CNBG Description and Business Overview
6.5.3 SIBP CNBG Live Herpes Zoster Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SIBP CNBG Live Herpes Zoster Vaccine Product Portfolio
6.5.5 SIBP CNBG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Herpes Zoster Vaccine Industry Chain Analysis
7.2 Live Herpes Zoster Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Herpes Zoster Vaccine Production Mode & Process
7.4 Live Herpes Zoster Vaccine Sales and Marketing
7.4.1 Live Herpes Zoster Vaccine Sales Channels
7.4.2 Live Herpes Zoster Vaccine Distributors
7.5 Live Herpes Zoster Vaccine Customers
8 Live Herpes Zoster Vaccine Market Dynamics
8.1 Live Herpes Zoster Vaccine Industry Trends
8.2 Live Herpes Zoster Vaccine Market Drivers
8.3 Live Herpes Zoster Vaccine Market Challenges
8.4 Live Herpes Zoster Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Companies
Merck
GSK
SK
Changchun BCHT Biotechnology
SIBP CNBG
List of Tables
 Table 1. Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Live Herpes Zoster Vaccine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Live Herpes Zoster Vaccine Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Live Herpes Zoster Vaccine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Live Herpes Zoster Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Live Herpes Zoster Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Live Herpes Zoster Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Live Herpes Zoster Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Live Herpes Zoster Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Live Herpes Zoster Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Herpes Zoster Vaccine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2024)
 Table 19. Global Live Herpes Zoster Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Live Herpes Zoster Vaccine Sales Market Share by Region (2025-2030)
 Table 21. Global Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2024)
 Table 23. Global Live Herpes Zoster Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Live Herpes Zoster Vaccine Revenue Market Share by Region (2025-2030)
 Table 25. North America Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Live Herpes Zoster Vaccine Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Live Herpes Zoster Vaccine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Live Herpes Zoster Vaccine Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Live Herpes Zoster Vaccine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2019-2024)
 Table 51. Global Live Herpes Zoster Vaccine Sales (K Dose) by Type (2025-2030)
 Table 52. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2019-2024)
 Table 53. Global Live Herpes Zoster Vaccine Sales Market Share by Type (2025-2030)
 Table 54. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2019-2024)
 Table 57. Global Live Herpes Zoster Vaccine Revenue Market Share by Type (2025-2030)
 Table 58. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2019-2024)
 Table 61. Global Live Herpes Zoster Vaccine Sales (K Dose) by Application (2025-2030)
 Table 62. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2019-2024)
 Table 63. Global Live Herpes Zoster Vaccine Sales Market Share by Application (2025-2030)
 Table 64. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Live Herpes Zoster Vaccine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2019-2024)
 Table 67. Global Live Herpes Zoster Vaccine Revenue Market Share by Application (2025-2030)
 Table 68. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2025-2030)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Merck Live Herpes Zoster Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. GSK Live Herpes Zoster Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. SK Company Information
 Table 81. SK Description and Business Overview
 Table 82. SK Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. SK Live Herpes Zoster Vaccine Product
 Table 84. SK Recent Developments/Updates
 Table 85. Changchun BCHT Biotechnology Company Information
 Table 86. Changchun BCHT Biotechnology Description and Business Overview
 Table 87. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Changchun BCHT Biotechnology Live Herpes Zoster Vaccine Product
 Table 89. Changchun BCHT Biotechnology Recent Developments/Updates
 Table 90. SIBP CNBG Company Information
 Table 91. SIBP CNBG Description and Business Overview
 Table 92. SIBP CNBG Live Herpes Zoster Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. SIBP CNBG Live Herpes Zoster Vaccine Product
 Table 94. SIBP CNBG Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Live Herpes Zoster Vaccine Distributors List
 Table 98. Live Herpes Zoster Vaccine Customers List
 Table 99. Live Herpes Zoster Vaccine Market Trends
 Table 100. Live Herpes Zoster Vaccine Market Drivers
 Table 101. Live Herpes Zoster Vaccine Market Challenges
 Table 102. Live Herpes Zoster Vaccine Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Live Herpes Zoster Vaccine
 Figure 2. Global Live Herpes Zoster Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Live Herpes Zoster Vaccine Market Share by Type: 2023 & 2030
 Figure 4. Single-dose Vaccination Product Picture
 Figure 5. Double-dose Vaccination Product Picture
 Figure 6. Global Live Herpes Zoster Vaccine Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Live Herpes Zoster Vaccine Market Share by Application: 2023 & 2030
 Figure 8. Public Health Sector
 Figure 9. Hospitals & clinics
 Figure 10. Others
 Figure 11. Global Live Herpes Zoster Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Live Herpes Zoster Vaccine Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Live Herpes Zoster Vaccine Sales (2019-2030) & (K Dose)
 Figure 14. Global Live Herpes Zoster Vaccine Average Price (US$/Dose) & (2019-2030)
 Figure 15. Live Herpes Zoster Vaccine Report Years Considered
 Figure 16. Live Herpes Zoster Vaccine Sales Share by Manufacturers in 2023
 Figure 17. Global Live Herpes Zoster Vaccine Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Live Herpes Zoster Vaccine Players: Market Share by Revenue in Live Herpes Zoster Vaccine in 2023
 Figure 19. Live Herpes Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Live Herpes Zoster Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
 Figure 22. North America Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
 Figure 23. United States Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
 Figure 26. Europe Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Live Herpes Zoster Vaccine Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Live Herpes Zoster Vaccine Revenue Market Share by Region (2019-2030)
 Figure 34. China Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Live Herpes Zoster Vaccine Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Live Herpes Zoster Vaccine Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Live Herpes Zoster Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Live Herpes Zoster Vaccine by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Live Herpes Zoster Vaccine by Type (2019-2030)
 Figure 53. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Live Herpes Zoster Vaccine by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Live Herpes Zoster Vaccine by Application (2019-2030)
 Figure 56. Global Live Herpes Zoster Vaccine Price (US$/Dose) by Application (2019-2030)
 Figure 57. Live Herpes Zoster Vaccine Value Chain
 Figure 58. Live Herpes Zoster Vaccine Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Varicella Live Vaccine Market Insights Forecast to 2030
Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Varicella Attenuated Live Vaccine Market Research Report 2025
Global Varicella Attenuated Live Vaccination Market Research Report 2025
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zoster Vaccine Live Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Varicella Vaccine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Varicella Vaccination Market Research Report 2025
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024
Global Acyclovir Injection Market Research Report 2024
Global Herpes Zoster Treatment Market Insights Forecast to 2030
Global Mumps Virus Vaccine Live Market Research Report 2024
Global Poultry Live Vaccines Market Research Report 2025
Global Live Poultry Vaccine Market Research Report 2025
Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions